Stay updated on Magrolimab vs. Venetoclax in TP53 AML Clinical Trial

Sign up to get notified when there's something new on the Magrolimab vs. Venetoclax in TP53 AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Magrolimab vs. Venetoclax in TP53 AML Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The study page now displays a 403 Forbidden error page instead of the study content, indicating an access/permission issue; as a result, users cannot view the study details on this page.
    Difference
    18%
    Check dated 2026-09-25T16:30:14.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.7.0, indicating a minor, behind-the-scenes update to the Study Details page.
    Difference
    0.0%
    Check dated 2026-09-18T17:59:02.000Z thumbnail image
  4. Check
    37 days ago
    Change Detected
    Summary
    The study documents on the page were updated to Revision: v3.6.6, replacing the previous v3.6.5, indicating an updated protocol/document set for the study.
    Difference
    0.0%
    Check dated 2026-08-28T17:49:05.000Z thumbnail image
  5. Check
    59 days ago
    Change Detected
    Summary
    Revision label updated from v3.6.4 to v3.6.5, indicating a minor page version update. The change is a metadata tag and does not modify study content or user-facing details.
    Difference
    0.0%
    Check dated 2026-08-07T10:13:32.000Z thumbnail image
  6. Check
    73 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.3 to v3.6.4, signaling a newer version of the study documentation or page content. This appears to be an administrative update rather than a substantive change to the study details.
    Difference
    0.0%
    Check dated 2026-07-24T02:47:25.000Z thumbnail image
  7. Check
    94 days ago
    Change Detected
    Summary
    The page revision tag was updated from v3.6.1 to v3.6.3, indicating a refreshed publication of the page. This change does not modify study details or outcomes; it serves as a metadata version update.
    Difference
    0.0%
    Check dated 2026-07-02T14:35:47.000Z thumbnail image

Stay in the know with updates to Magrolimab vs. Venetoclax in TP53 AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Magrolimab vs. Venetoclax in TP53 AML Clinical Trial page.